| Primary |
| Psoriasis |
47.5% |
| Drug Use For Unknown Indication |
17.2% |
| Ichthyosis |
4.5% |
| Keratosis Follicular |
4.0% |
| Product Used For Unknown Indication |
3.4% |
| Pustular Psoriasis |
3.1% |
| Pityriasis Rubra Pilaris |
2.5% |
| Mycosis Fungoides |
2.3% |
| Pruritus |
2.3% |
| Rash Papular |
1.7% |
| Squamous Cell Carcinoma |
1.7% |
| Contraception |
1.4% |
| Hyperkeratosis Palmaris And Plantaris |
1.4% |
| Pain |
1.4% |
| Skin Disorder |
1.4% |
| Insomnia |
1.1% |
| Dermatitis |
0.8% |
| Prophylaxis |
0.8% |
| Psoriatic Arthropathy |
0.8% |
| Angelman's Syndrome |
0.6% |
|
| Pregnancy |
29.6% |
| Transmission Of Drug Via Semen |
10.4% |
| Live Birth |
5.9% |
| Renal Impairment |
5.2% |
| Pyogenic Granuloma |
4.4% |
| Skin Exfoliation |
4.4% |
| Drug Exposure During Pregnancy |
3.7% |
| Pregnancy Of Partner |
3.7% |
| Psoriasis |
3.7% |
| Tendonitis |
3.7% |
| Weight Decreased |
3.7% |
| Hypercholesterolaemia |
3.0% |
| Rash Maculo-papular |
3.0% |
| Atrial Fibrillation |
2.2% |
| Leukopenia |
2.2% |
| Liver Function Test Abnormal |
2.2% |
| Malaise |
2.2% |
| Musculoskeletal Stiffness |
2.2% |
| Neutropenia |
2.2% |
| Peripheral Sensory Neuropathy |
2.2% |
|
| Secondary |
| Psoriasis |
36.6% |
| Pustular Psoriasis |
11.2% |
| Product Used For Unknown Indication |
9.0% |
| Drug Use For Unknown Indication |
6.3% |
| Dermatitis Atopic |
5.6% |
| Pruritus |
4.5% |
| Psoriatic Arthropathy |
4.1% |
| Ill-defined Disorder |
3.0% |
| Keratosis Follicular |
3.0% |
| Prophylaxis |
3.0% |
| Insomnia |
1.9% |
| Depression |
1.5% |
| Hormone Replacement Therapy |
1.5% |
| Hypertension |
1.5% |
| Psychiatric Symptom |
1.5% |
| Skin Cancer |
1.5% |
| Depressive Symptom |
1.1% |
| Erythrodermic Psoriasis |
1.1% |
| Mania |
1.1% |
| Mycosis Fungoides |
1.1% |
|
| Pustular Psoriasis |
18.3% |
| Completed Suicide |
13.3% |
| Malignant Melanoma |
6.7% |
| Psoriasis |
6.7% |
| Cheilitis |
5.0% |
| Rash |
5.0% |
| Sinus Bradycardia |
5.0% |
| Squamous Cell Carcinoma |
5.0% |
| Basal Cell Carcinoma |
3.3% |
| Leukopenia |
3.3% |
| Lung Neoplasm Malignant |
3.3% |
| Myopathy |
3.3% |
| Rash Generalised |
3.3% |
| Swelling |
3.3% |
| Syndesmophyte |
3.3% |
| Upper Respiratory Tract Infection |
3.3% |
| Urinary Tract Infection |
3.3% |
| Acute Myocardial Infarction |
1.7% |
| Atrial Fibrillation |
1.7% |
| Blood Thyroid Stimulating Hormone Decreased |
1.7% |
|
| Concomitant |
| Psoriasis |
34.0% |
| Product Used For Unknown Indication |
29.4% |
| Pustular Psoriasis |
7.8% |
| Drug Use For Unknown Indication |
5.4% |
| Hypertension |
3.9% |
| Psoriatic Arthropathy |
2.7% |
| Diabetes Mellitus |
2.2% |
| Pain |
1.6% |
| Pruritus |
1.6% |
| Colitis Ulcerative |
1.3% |
| Dermatitis Atopic |
1.3% |
| Erythrodermic Psoriasis |
1.3% |
| Herpes Simplex |
1.3% |
| Pityriasis Rubra Pilaris |
1.2% |
| Insulin-requiring Type 2 Diabetes Mellitus |
1.0% |
| Iridocyclitis |
1.0% |
| T-cell Lymphoma |
0.9% |
| Dermatitis |
0.8% |
| Rheumatoid Arthritis |
0.8% |
| Blood Cholesterol |
0.6% |
|
| Psoriasis |
11.7% |
| T-cell Lymphoma |
11.7% |
| Pustular Psoriasis |
7.4% |
| Weight Decreased |
7.4% |
| Erythrodermic Psoriasis |
5.3% |
| Squamous Cell Carcinoma Of Skin |
5.3% |
| Tuberculosis |
5.3% |
| Vomiting |
5.3% |
| Lung Neoplasm Malignant |
4.3% |
| Nodule |
4.3% |
| Prostate Cancer |
4.3% |
| Squamous Cell Carcinoma |
4.3% |
| Acute Myocardial Infarction |
3.2% |
| Dermatitis Bullous |
3.2% |
| Neutropenia |
3.2% |
| Rash |
3.2% |
| Skin Ulcer |
3.2% |
| Therapy Non-responder |
3.2% |
| Acute Generalised Exanthematous Pustulosis |
2.1% |
| Cellulitis |
2.1% |
|
| Interacting |
| Pustular Psoriasis |
26.9% |
| Psychiatric Symptom |
23.1% |
| Prophylaxis |
15.4% |
| Depression |
11.5% |
| Breast Cancer |
7.7% |
| Arthritis Infective |
3.8% |
| Mental Disorder |
3.8% |
| Psoriasis |
3.8% |
| Psoriatic Arthropathy |
3.8% |
|
| Drug Interaction |
33.3% |
| Sinus Bradycardia |
33.3% |
| Psoriasis |
16.7% |
| Hepatic Enzyme Increased |
8.3% |
| White Blood Cell Count Decreased |
8.3% |
|
